Reme-D raises $1.4M series a

◆ Amount

$1.4M

◆ Announced

23 Jul 2026

◆ Company

◆ Source

◆ The Round

Reme-D raised $1.4M in series a funding, announced on 23 July 2026, led by Anara Impact Capital, with participation from Global Innovation Fund, Africa Health Ventures. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Reme-D

Egyptian healthtech startup that develops and manufactures molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV. Reme-D is based in Egypt and currently at series a stage, operating in healthtech, diagnostics.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Reme-D's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market